Frontlight ResearchEarly access
Trial site
SCRI Oncology Partners (Site 7000)
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Neuroendocrine tumours1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Completed1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC7 trials
Running trials
Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Recruiting
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Recruiting
Recruiting
Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026